MedTrace Logo

Omega-3 and Aspirin in Periodontal Regeneration

NCT01113528 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-05-14

No results posted yet for this study

Summary

To evaluate the efficacy of systemic administration of omega 3 PUFA plus low dose aspirin as an adjunctive therapy to regenerative modality of grade II furcation defects in periodontitis patients.

Conditions

  • Periodontal Disease

Interventions

OTHER

Regenerative therapy (omega 3 PUFA plus low dose aspirin)

Comparison between regenerative bone graft alone and bone graft + Omega-3 and low dose aspirin

DRUG

Sugar pill

3 times daily

Sponsors & Collaborators

  • Cairo University

    collaborator OTHER

  • October 6 University

    lead OTHER

Principal Investigators

  • Amr M. Elkhouli, ph.D · October 6 University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2009-12-31
Completion
2010-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01113528 on ClinicalTrials.gov